BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19588166)

  • 1. Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.
    Abdul-Ghani RA; Loutfy N; Hassan A
    Parasitol Res; 2009 Oct; 105(4):899-906. PubMed ID: 19588166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosomiasis control: praziquantel forever?
    Cioli D; Pica-Mattoccia L; Basso A; Guidi A
    Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
    Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
    ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward organometallic antischistosomal drug candidates.
    Hess J; Keiser J; Gasser G
    Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
    Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
    Front Immunol; 2021; 12():642383. PubMed ID: 34135888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis--a century searching for chemotherapeutic drugs.
    Ribeiro-dos-Santos G; Verjovski-Almeida S; Leite LC
    Parasitol Res; 2006 Oct; 99(5):505-21. PubMed ID: 16636847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of artemether for the control of schistosomiasis.
    Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
    Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance to schistosomicides and other anthelmintics of medical significance.
    Brindley PJ
    Acta Trop; 1994 Mar; 56(2-3):213-31. PubMed ID: 8203304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
    Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
    Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
    [No Abstract]   [Full Text] [Related]  

  • 13. Will new antischistosomal drugs finally emerge?
    Cioli D; Valle C; Angelucci F; Miele AE
    Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in research on antischistosomal drugs].
    Qiu SJ; Xia CM
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives.
    Peter Ventura AM; Haeberlein S; Konopka L; Obermann W; Grünweller A; Grevelding CG; Schlitzer M
    Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100259. PubMed ID: 34523746
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Guerra RA; Silva MP; Silva TC; Salvadori MC; Teixeira FS; de Oliveira RN; Rocha JA; Pinto PLS; de Moraes J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.
    Mafud AC; Ferreira LG; Mascarenhas YP; Andricopulo AD; de Moraes J
    Trends Parasitol; 2016 Nov; 32(11):874-886. PubMed ID: 27593339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 1,3-benzodioxole derivatives: Synthesis, evaluation of in vitro schistosomicidal activity and ultrastructural analysis.
    Mariz Gomes da Silva LM; de Oliveira JF; Silva WL; da Silva AL; de Almeida Junior ASA; Barbosa Dos Santos VH; Alves LC; Brayner Dos Santos FA; Costa VMA; Aires AL; de Lima MDCA; Albuquerque MCPA
    Chem Biol Interact; 2018 Mar; 283():20-29. PubMed ID: 29366735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving translational power in antischistosomal drug discovery.
    Probst A; Biendl S; Keiser J
    Adv Parasitol; 2022; 117():47-73. PubMed ID: 35878949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.